Search

Your search keyword '"Knoll, T"' showing total 656 results

Search Constraints

Start Over You searched for: Author "Knoll, T" Remove constraint Author: "Knoll, T"
656 results on '"Knoll, T"'

Search Results

401. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate.

402. Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology.

403. Ureteroscopy for stone treatment using new 270 degrees semiflexible endoscope: in vitro, ex vivo, and clinical application.

404. 980-nm Diode laser: a novel laser technology for vaporization of the prostate.

405. Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones.

406. 2007 guideline for the management of ureteral calculi.

407. Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center.

408. A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access.

410. Ablation of clinically relevant kidney tissue volumes by high-intensity focused ultrasound: Preliminary results of standardized ex-vivo investigations.

411. [Ureterorenoscopy: yesterday, today, tomorrow].

412. Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells.

413. Risk of collateral damage to endourologic tools by holmium:YAG laser energy.

414. [Retroperitoneoscopy to extract an amorphous matrix calculus of the right kidney].

415. Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumours.

416. Bipolar and multipolar radio frequency ablation with resistance controlled power output: standardized ex vivo kidney tissue evaluation.

417. Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life.

418. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.

419. Urothelial carcinoma of the ureter, giant rectal stone and sigmoid carcinoma 55 years after ureterosigmoidostomy.

420. New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation.

421. Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devices.

422. Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases.

423. Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek?

424. Validation of computer-based training in ureterorenoscopy.

425. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy.

426. [Clinical value of percutaneous nephrolithotomy].

427. [Current aspects of stone therapy].

428. Prostate cancer therapy: standard management, new options and experimental approaches.

429. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

430. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.

431. High-intensity focused ultrasound for ex vivo kidney tissue ablation: influence of generator power and pulse duration.

432. Micelle delivery of doxorubicin increases cytotoxicity to prostate carcinoma cells.

433. The influence of oxalate on renal epithelial and interstitial cells.

434. Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells.

435. In vitro and ex vivo gene delivery into proximal tubular cells by means of laser energy--a potential approach for curing cystinuria?

436. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.

437. Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer.

439. [Urodynamic findings in patients with infantile cerebral palsy].

440. Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma.

441. In vitro transfection of human bladder cancer cells by acoustic energy.

442. [Metachronous testicular tumor of an extragonadal germ cell tumor].

443. [Minimally-invasive therapy of urinary stones].

444. Measurement of renal anatomy for prediction of lower-pole caliceal stone clearance: reproducibility of different parameters.

445. Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol.

447. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.

448. [Established and new urological therapeutic options in the management of prostate carcinoma].

449. [Sacral neuromodulation in patients with nonobstructive, chronic urinary retention: relevance of the carbachol test and influence of associated nerve lession].

450. The role of the carbachol test and concomitant diseases in patients with nonobstructive urinary retention undergoing sacral neuromodulation.

Catalog

Books, media, physical & digital resources